Epidemiological profile of masked hypertension diagnosed by ambulatory blood pressure monitoring Hypertension Unit Centro Cardiovascular Regional Centro Occidental

Authors

  • Juan Cárdenas Universidad Centroccidental Lisandro Alvarado

Keywords:

prehypertension, hypertension, blood pressure monitoring, ambulatory, tobacco use disorder, sleepiness

Abstract

Arterial hypertension is the most important cardiovascular risk factor in the western hemisphere. Masked hypertension (MHT), a missing link in the hypertensive syndrome for many researchers, remains an enigma to be clarified. Scientific evidence in recent years indicates that MHT is a phenomenon that is related to high rates of morbidity and mortality. The aim of this study is to describe the epidemiological profile of patients with MHT diagnosed by ambulatory blood pressure monitoring (ABPM) in the Hypertension Unit of the Centro Occidental Regional Cardiovascular Center, during the period June 2015-2020. A descriptive, cross-sectional, study was carried out which included 85 patients who met the ABPM criteria for MHT. The results show that the female sex (53%) had the highest prevalence and the mean age of the sample was 47 ± 22 years old. In 26% and 80% of patients a history of smoking and sedentary lifestyle was observed. Pathological hypersomnolence was observed in 26% of patients determined by the Epworth scale. The main associated comorbidity was diabetes (28%) followed by dyslipidemia (18%). There was a higher proportion of MHT in women, between the fifth and sixth decade of life, with a higher prevalence in patients with a history of diabetes, dyslipidemia and sedentary habits.

Downloads

Download data is not yet available.

References

Javed A, Palla M, Afonso L, Briasoulis A. Masked hypertension and cardiovascular outcomes: An update systematic review and meta-analysis. Integr Blood Press Control 2018; 11:11-24.

Mancia G, Fagart R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159–2219.

Banegas J, Ruilope L, de la Sierra A, Vinyoles E, Gorostidi M., de la Cruz J, Ruiz-et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med 2018; 378: 1509-20.

Kostantopoulou A, Kostantopoulou P, Papargyriou I, Liatis S, Stergiou G, Papadogiannis, D. Masked, white coat and sustained hypertension: comparison of target organs and psychometrics parameters. J Hypertens 2010; 24: 151-157.

Hänninen M, Niiranen T, Puukka P, Mattila A, Jula A. Determinants of masked hypertension in the general population: the Finn-Home Study. J Hypertens 2011; 29: 1880-1888.

Mwasongwe S, Min Y, Booth III J, Katz R, Sims M, Correa A, et al. Masked hypertension and kidney function decline: the Jackson Heart Study. J Hypertens 2018; 36: 1524-1532.

Stergiou G, Asayama K, Thijs L, Kollias A, Niiranen T, Hozawa A, et al. Prognosis on White coat Hypertension and Masked Hypertension. International data base on home blood pressure in relation to Cardiovascular Outcome. Hypertension 2014; 63: 675-682.

Johns M. A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale. Sleep 1991; 14(6): 540-545.

Published

2022-04-19

How to Cite

Cárdenas, J. (2022). Epidemiological profile of masked hypertension diagnosed by ambulatory blood pressure monitoring Hypertension Unit Centro Cardiovascular Regional Centro Occidental. Boletin Médico De Postgrado, 38(1), 30-35. Retrieved from https://revistas.uclave.org/index.php/bmp/article/view/3848

Issue

Section

Artículos originales